Triad pharmaceutical company gets tentative approval for drug treating MS

Banner Life Sciences of High Point has received tentative approval for a potential drug intended to treat patients with relapsing forms of multiple sclerosis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.